tiprankstipranks
Ecovyst Inc (ECVT)
NYSE:ECVT
US Market
Want to see ECVT full AI Analyst Report?

Ecovyst (ECVT) Earnings Dates, Call Summary & Reports

186 Followers

Earnings Data

Report Date
Jul 30, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.19
Last Year’s EPS
0.12
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented strong operational and financial momentum: substantial y/y revenue and adjusted EBITDA growth, robust liquidity, active capital returns via $36 million of share repurchases, and a strategic acquisition (Calabrian) that expands the product portfolio and geographic reach. Offsetting these positives are macro-driven challenges—historic sulfur cost spikes that create sales pass-through and margin percentage pressure, elevated manufacturing/transportation/turnaround costs, some quarter-to-quarter volume timing headwinds for virgin sulfuric acid, and modest near-term free cash flow due to seasonality and working-capital timing. Management tightened guidance while raising the sales range to reflect sulfur pass-through and signaled moderate additional interest expense to finance the acquisition. On balance, the operational gains, balance sheet flexibility, and strategic M&A progress outweigh the near-term cost and timing headwinds.
Company Guidance
The company tightened 2026 guidance (excluding any contributions from the announced Calabrian acquisition) and now expects full-year sales of $890 million to $970 million (up vs. prior $860M–$940M range reflecting ~$30M of incremental sulfur cost pass‑through), adjusted EBITDA of $180 million to $195 million (midpoint $187.5M), and adjusted free cash flow of $40 million to $55 million; quarterly directional EBITDA ranges are Q2 $50M–$55M, Q3 $50M–$55M and Q4 $40M–$45M, with Q2 turnaround costs lower than a year ago but higher turnaround costs expected in Q3 and Q4, and sulfur costs anticipated to ease in Q4. In Q1 the company delivered sales of $215M (up $72M YoY), adjusted EBITDA of $40M (up $19M, +87% YoY), adjusted free cash flow of $4M, net debt of $234M (leverage 1.2x), available liquidity of $237M (cash $163M, ABL $74M), repurchased $36M of stock at ~ $11/share (with $146M remaining authorization), and realized about $33M of sulfur pass‑through on sales (excluding pass‑through, sales were up ~27% and price‑to‑cost uplift was ~$11M, with ~$15M of the EBITDA gain driven by higher volumes including Wagaman). Management expects to fund the $190M Calabrian purchase (TTM adj. EBITDA ~ $24M; ~8x purchase multiple, stepping to ~7x with synergies) with cash and debt (pro forma net debt leverage at close ~2x) and anticipates cash interest to rise ~$4M–$5M annually to finance part of the deal; the acquisition is expected to close by the end of Q2.
Positive Price-to-Cost Dynamics
Excluding sulfur pass-through, the price-to-cost uplift contributed roughly $11 million to Q1 results, with nearly $15 million of the period-over-period increase in adjusted EBITDA attributable to higher sales volume (including Wagaman).
Balance Sheet and Liquidity Strength
Quarter-end liquidity of $237 million (cash $163 million and ABL availability $74 million); net debt $234 million with a net debt leverage ratio of 1.2x unchanged from year-end.
Share Repurchase and Capital Return
Repurchased approximately $36 million of common stock in Q1 at an average price of ~$11 per share; $146 million remaining under the repurchase authorization.
Accretive M&A Pipeline and Calabrian Announcement
Agreement to acquire Calabrian sulfur dioxide and sulfur derivatives business for $190 million on a trailing twelve-month adjusted EBITDA of ~$24 million (~8x multiple, expected to step to ~7x with synergies); acquisition expected to close by end of Q2 and broaden product portfolio and end-market exposure (mining, water treatment, pharma, food).
Upward Sales Guidance and Tightened Profit Guidance
Full-year 2026 sales guidance raised to $890 million–$970 million (from $860 million–$940 million) reflecting higher sulfur cost pass-through; full-year adjusted EBITDA guidance tightened to $180 million–$195 million (midpoint $187.5 million); adjusted free cash flow guidance tightened to $40 million–$55 million.
Strong Adjusted EBITDA Growth
Adjusted EBITDA of $40 million in Q1 2026, up $19 million or 87% versus Q1 2025, driven by higher volumes and favorable pricing.
Material Sales Increase
Total sales of $215 million in Q1 2026, up $72 million or 50% year-over-year; excluding approximately $33 million of sulfur cost pass-through, sales were up nearly 27%.
Regeneration Services and Virgin Sulfuric Acid Volume Strength
Regeneration Services sales rose on a double-digit percentage basis due to high U.S. refinery utilization, favorable alkylation economics, and lower customer downtime; virgin sulfuric acid sales were up significantly benefiting from increased mining demand and contribution from the Wagaman assets acquired in 2025.

Ecovyst (ECVT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ECVT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 30, 2026
2026 (Q2)
0.19 / -
0.12
May 05, 2026
2026 (Q1)
0.05 / 0.11
0.011000.00% (+0.10)
Feb 26, 2026
2025 (Q4)
0.15 / 0.28
0.280.00% (0.00)
Nov 04, 2025
2025 (Q3)
0.15 / 0.19
0.1435.71% (+0.05)
Aug 07, 2025
2025 (Q2)
0.10 / 0.12
0.120.00% (0.00)
May 01, 2025
2025 (Q1)
-0.03 / 0.01
0.04-75.00% (-0.03)
Feb 27, 2025
2024 (Q4)
0.24 / 0.28
0.2227.27% (+0.06)
Oct 31, 2024
2024 (Q3)
0.17 / 0.14
0.19-26.32% (-0.05)
Aug 01, 2024
2024 (Q2)
0.13 / 0.12
0.29-58.62% (-0.17)
May 02, 2024
2024 (Q1)
0.05 / 0.04
0.06-33.33% (-0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ECVT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 05, 2026
$14.12$14.73+4.32%
Feb 26, 2026
$11.32$11.45+1.15%
Nov 04, 2025
$8.27$7.84-5.20%
Aug 07, 2025
$8.39$8.20-2.26%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Ecovyst Inc (ECVT) report earnings?
Ecovyst Inc (ECVT) is schdueled to report earning on Jul 30, 2026, Before Open (Confirmed).
    What is Ecovyst Inc (ECVT) earnings time?
    Ecovyst Inc (ECVT) earnings time is at Jul 30, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ECVT EPS forecast?
          ECVT EPS forecast for the fiscal quarter 2026 (Q2) is 0.19.